The OJC 51: Prostate Cancer Screening, ASCO IO Guidelines and Infigratinib - podcast episode cover

The OJC 51: Prostate Cancer Screening, ASCO IO Guidelines and Infigratinib

Oct 06, 202151 minSeason 1Ep. 51
--:--
--:--
Download Metacast podcast app
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episode description

Send us Fan Mail

The Oncology Journal Club - Delivering Oncology News Differently

The Oncology Podcast, brought to you by Oncology News Australia, is proud to present Episode 51 in our series The Oncology Journal Club.

Welcome to this week's episode of The OJC. Join Eva Segelov, Craig Underhill and Hans Prenen as they review an eclectic mix of papers covering prostate cancer screening, ASCO guidelines for immunotherapy for locally advanced esophageal carcinoma, infigratinib in advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements, Quick Bites, Zoom Fatigue and much, much more!

We hope you enjoy the Amazing Article of the Week, the Practice Tip of the Week and have a few laughs too.

Full bios and the list of all papers discussed are available on our website.

For the latest oncology news visit
www.oncologynews.com.au and for regular oncology updates for healthcare professionals, subscribe for free to get the weekly The Oncology Newsletter.

The Oncology Podcast - An Australian Oncology Perspective

For the best experience, listen in Metacast app for iOS or Android